Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
iCo-007 for Diabetic Macular Edema (iDEAL)
NCT01565148Phase 2Terminated
- Sponsor
- Johns Hopkins University
- Start
- Feb 2012
- Primary completion
- Feb 2014
- Modality
- Modified DNA Oligonucleotides, Single-strand DNA, Antisense Oligonucleotides (ASOs)
- Countries
- 1
01
Overview
A Phase 2 trial of ico-007 in diabetic macular edema (DME), sponsored by Johns Hopkins University. Started Feb 2012; status: terminated.
02
Drugs
ico-007
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT01565148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01565148.